- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 453978, 4 pages
What Is the Incidence of Intracranial Bleeding in Patients with Mild Traumatic Brain Injury? A Retrospective Study in 3088 Canadian CT Head Rule Patients
1Department of Emergency Medicine, University Hospital Bern (Inselspital), University of Bern, 3010 Bern, Switzerland
2Department of Neurosurgery, Red Cross Hospital, 11526 Athens, Greece
Received 9 April 2013; Accepted 23 June 2013
Academic Editor: Andrew Ducruet
Copyright © 2013 C. E. Albers et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective. Only limited data exists in terms of the incidence of intracranial bleeding (ICB) in patients with mild traumatic brain injury (MTBI). Methods. We retrospectively identified 3088 patients (mean age 41 range (7–99) years) presenting with isolated MTBI and GCS 14-15 at our Emergency Department who had undergone cranial CT (CCT) between 2002 and 2011. Indication for CCT was according to the “Canadian CT head rules.” Patients with ICB were either submitted for neurosurgical treatment or kept under surveillance for at least 24 hours. Pearson’s correlation coefficient was used to correlate the incidence of ICB with age, gender, or intake of coumarins, platelet aggregation inhibitors, or heparins. Results. 149 patients (4.8%) had ICB on CCT. No patient with ICB died or deteriorated neurologically. The incidence of ICB increased with age and intake of anticoagulants without clinically relevant correlation (; ; ; ). Conclusion. Our data show an incidence of 4.8% for ICB after MTBI. However, neurological deterioration after MTBI seems to be rare, and the need for neurosurgical intervention is only required in selected cases. The general need for CCT in patients after MTBI is therefore questionable, and clinical surveillance may be sufficient when CCT is not available.
Mild traumatic brain injury (MTBI) is a major public health concern for both children and adults and represents 70–90% of all treated traumatic brain injuries [1, 2]. Prognosis after MTBI is a central issue in health care and is related to both the identification of individuals at risk of poor recovery and identification of modifiable risk factors and feasible treatment strategies . Cranial CT without contrast (CCT) has become the gold standard to detect structural brain injury after traumatic brain injury. Several studies have been carried out to investigate both intracranial structural abnormalities and clinical symptoms and neurological deterioration after MTBI [4–8]. Stiell et al. reviewed more than 3000 patients undergoing CCT after MTBI in a prospective multicenter study and found clinically important brain injuries in 8% of all cases . The authors proposed a score for the performance of CCT after MTBI, and this has become known as the Canadian CT head rules . The indication for CCT in our department is in accordance with the Canadian CT head rules . In case of an intracerebral bleed, a neurosurgeon has to be formally consulted. Patients with clinically unimportant brain injury undergo admission for 24 hours surveillance in the Emergency Department. Clinical surveillance comprises the assessment of GCS every 15 minutes for the first hour, every 30 minutes for the next 2 hours, and every hour for the following 21 hours . However, it is not yet clear whether CCT is useful for all patients with MTBI and a Glasgow Coma Scale score (GCS) of 14-15 points, or whether clinical surveillance may be superior [2, 8, 10–12]. This study aimed at investigating the incidence of ICB, neurological deterioration, and possible risk factors, in a large consecutive group of European patients with isolated MTBI on admission.
A retrospective study was conducted. Using our electronic patient records; we identified all patients presenting with isolated MTBI and GCS 14-15 at our Emergency Department (Level I trauma centre) between January 1, 2002 and December 31, 2011. All patients underwent CCT within less than 6 hours of their accident. Patients with GCS <14, missing or incomplete CCT data, or no clear history of trauma were excluded from the study. The indication for CCT was set according to the guidelines of the Canadian CT head rules . Diagnostic findings from CCT were evaluated for intracranial bleeding (ICB). If structural brain injuries were found on CCT, patients were either submitted for further neurosurgical treatment or kept under surveillance for at least 24 hours, in order to assure early recognition of neurological deterioration related to MTBI. The type of ICB (epidural haematoma, subdural haematoma, subarachnoid haemorrhage, or intracerebral haematoma) was noted. Patients with anticoagulant medication (coumarins, platelet aggregation inhibitors, or heparins) were identified. The mechanisms of injury were noted. Statistical analyses included the determination of Pearson’s correlation coefficient for age, gender, and the intake of coumarins, platelet aggregation inhibitors, or heparins with ICB . A value <0.05 was accepted as statistically significant. This study was approved by the institutional review board.
A total of 3088 patients were identified. The mean age at the time of trauma was (range: 16–99) years. Sixty-one percent of all patients were male. 149 patients (4.8%) were found to have ICB on CCT (62% male). The different types of ICB (epidural, subdural haematoma, subarachnoid, and intracerebral haemorrhage) as well as gender distribution are shown in Table 1. No patient with ICB died or deteriorated neurologically after a minimum follow up 24 hours of clinical surveillance. The incidence of ICB after MTBI increased with age and the intake of anticoagulants. However, there was no clinically relevant correlation of ICB with age (; ), gender (; ), or the intake of anticoagulant drugs (; ) (Figure 1). The main mechanisms of accident were falls, road accidents, violence, and sports.
The present study aimed at investigating the incidence of ICB after MTBI. Of all 3088 patients, 149 (4.8%) presented with an ICB on CCT. There were no patients with neurological deterioration after 24 hours surveillance. None of the investigated risk factors showed a clinically relevant correlation with ICB.
There is still no broad agreement in terms of the need for CCT in patients with GCS 14-15 after MTBI [2, 8, 11–13]. Several studies have found similar results with regard to the incidence of ICB after MTBI [8, 14, 15]. Our data suggest that clinical surveillance seems to be sufficient and CCT may not be necessary in the acute phase, as none of the patients in this study presented with neurological deterioration. This would reduce unnecessary exposure to radiation and save radiology resources. A recent study showed that even admission and observation are not required in a subset of adult patients without risk factors for bleeding (e.g., anticoagulant therapy, intoxication, and concomitant injuries), suggesting a more liberal policy of early home monitoring . On the other hand, minor bleeding found on CCT may guide the clinician with regard to mid- and long-term followup, since some patients may require elective neurological treatment due to secondary neurocognitive disorders related to MTBI. This may include postconcussion syndrome (PCS) [5, 7] or posttraumatic secondary epilepsy. Several studies showed considerable negative effects on the patient’s ability to return to preinjury function, or to work or attend school after MTBI [16–21].
This study has limitations. Due to the retrospective study design; this study includes only patients who had undergone CCT, thus neglecting those without CCT and GCS 14-15. For the latter, no followup was obtained and no outcome measure can be reported. However, in accordance with our in house policy, all patients with a history of trauma and fulfilling the Canadian CT hear rules were included. As this is a large patient series, we believe that this selection bias can be neglected. Furthermore, the intake of coumarins, platelet aggregation inhibitors, or heparins was not substantiated by specific laboratory measures such as INR or thrombin time. Therefore, no conclusions can be drawn with regard to the degree of anticoagulation.
Our data show an incidence of 4.8% for ICB after MTBI. However, neurological deterioration after MTBI seems to be rare, and the need for neurosurgical intervention is only required in the selected cases. Anticoagulants, age, or gender do not seem to relevantly increase the risk of ICB. The general need for cranial CT in patients after MTBI is therefore questionable, and clinical surveillance may be sufficient when cranial CT is not available. Nevertheless, a CCT may be performed in patients whose comorbidities or concomitant injuries prohibit proper clinical/neurological assessment or surveillance.
- C. Cancelliere, J. D. Cassidy, P. Cote, C. A. Hincapie, J. Hartvigsen, and L. J. Carroll, “Protocol for a systematic review of prognosis after mild traumatic brain injury: an update of the WHO Collaborating Centre Task Force findings,” Systematic Reviews, vol. 1, article 17, 2012.
- J. D. Cassidy, L. J. Carroll, P. M. Peloso et al., “Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on mild traumatic brain injury,” Journal of Rehabilitation Medicine, vol. 36, no. 43, pp. 28–60, 2004.
- E. W. Steyerberg, Clinical Prediction Models: A Practical Approach to Development , Validation and Updating, Springer, New York, NY, USA, 2009.
- S. Galbraith, “Misdiagnosis and delayed diagnosis in traumatic intracranial haematoma,” British Medical Journal, vol. 1, no. 6023, pp. 1438–1439, 1976.
- X. Gao and J. Chen, “Mild traumatic brain injury results in extensive neuronal degeneration in the cerebral cortex,” Journal of Neuropathology and Experimental Neurology, vol. 70, no. 3, pp. 183–191, 2011.
- L. F. Marshall, B. M. Toole, and S. A. Bowers, “The National Traumatic Coma Data Bank—part 2. Patients who talk and deteriorate: implications for treatment,” Journal of Neurosurgery, vol. 59, no. 2, pp. 285–288, 1983.
- R. M. Ruff, “Mild traumatic brain injury and neural recovery: rethinking the debate,” NeuroRehabilitation, vol. 28, no. 3, pp. 167–180, 2011.
- I. G. Stiell, G. A. Wells, K. Vandemheen et al., “The Canadian CT Head Rule for patients with minor head injury,” Lancet, vol. 357, no. 9266, pp. 1391–1396, 2001.
- B. Schaller, D. S. Evangelopoulos, C. Müller et al., “Do we really need 24-h observation for patients with minimal brain injury and small intracranial bleeding? The Bernese trauma unit protocol,” Emergency Medicine Journal, vol. 27, no. 7, pp. 537–539, 2010.
- K. Pearson, “Determination of the coefficient of correlation,” Science, vol. 30, no. 757, pp. 23–25, 1909.
- S. Dalbayrak, S. Gumustas, A. Bal, and G. Akansel, “Early and delayed CT findings in patients with mild-to-moderate head trauma,” Turkish Neurosurgery, vol. 21, no. 4, pp. 591–598, 2011.
- A. I. Maas, N. Stocchetti, and R. Bullock, “Moderate and severe traumatic brain injury in adults,” The Lancet Neurology, vol. 7, no. 8, pp. 728–741, 2008.
- M. Smits, D. W. J. Dippel, G. G. De Haan et al., “Minor head injury: guidelines for the use of CT—a multicenter validation study,” Radiology, vol. 245, no. 3, pp. 831–838, 2007.
- K. K. Nagy, K. T. Joseph, S. M. Krosner et al., “The utility of head computed tomography after minimal head injury,” Journal of Trauma, vol. 46, no. 2, pp. 268–270, 1999.
- S. C. Stein, I. G. Stiell, A. Laupacis et al., “Indications for computed tomography after minor head injury,” New England Journal of Medicine, vol. 343, no. 21, pp. 1570–1571, 2000.
- E. E. Andersson, B. K. Bedics, and T. Falkmer, “Mild traumatic brain injuries: a 10-year follow-up,” Journal of Rehabilitation Medicine, vol. 43, no. 4, pp. 323–329, 2011.
- H. G. Belanger, G. Curtiss, J. A. Demery, B. K. Lebowitz, and R. D. Vanderploeg, “Factors moderating neuropsychological outcomes following mild traumatic brain injury: a meta-analysis,” Journal of the International Neuropsychological Society, vol. 11, no. 3, pp. 215–227, 2005.
- M. A. Zumstein, M. Moser, M. Mottini et al., “Long-term outcome in patients with mild traumatic brain injury: a prospective observational study,” Journal of Trauma, vol. 71, no. 1, pp. 120–127, 2011.
- C. W. Hoge, D. McGurk, J. L. Thomas, A. L. Cox, C. C. Engel, and C. A. Castro, “Mild traumatic brain injury in U.S. soldiers returning from Iraq,” New England Journal of Medicine, vol. 358, no. 5, pp. 453–463, 2008.
- N. Garga and D. H. Lowenstein, “Posttraumatic epilepsy: a major problem in desperate need of major advances,” Epilepsy Currents/American Epilepsy Society, vol. 6, pp. 1–5, 2006.
- W. A. Hauser, J. F. Annegers, and L. T. Kurland, “Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984,” Epilepsia, vol. 34, no. 3, pp. 453–468, 1993.